axsome.com (AXSM): Expected earnings per share growth for next year
Axsome Therapeutics (AXSM) specializes in developing targeted treatments for Alzheimer's and depression. The daily price action of analyst expectations for EPS n+1 growth on the GURU.Markets chart shows that the 237.30 metric serves as the target level. The success of Auvelity and the launch of migraine medications act as drivers, while an efficient R&D pipeline ensures the commercialization of new drugs for narcolepsy.
Metric breakdowns and analytics for axsome.com (AXSM)
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- book capitalization information:
- company total debt and liquidity indicators:
Total Debt to Capital Axsome Therapeutics|AXSM - Long-Term Liabilities to Capital|Short-Term Debt to Equity Axsome Therapeutics, Inc.|AXSM - Aggregate Debt Obligations|Debts to Book Capitalization Axsome Therapeutics|AXSM - Company Long-Term Debts|Company Short-Term Debt Axsome Therapeutics|Quick Ratio axsome.com
- earnings and market ratios statistics:
AXSM - Company Net Income|Future Profit Axsome Therapeutics|AXSM - P/E Multiple|Projected Price to Earnings Axsome Therapeutics|AXSM - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Axsome Therapeutics|AXSM - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Axsome Therapeutics|AXSM - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months axsome.com|AXSM - Expected net earnings per share growth this year|Earnings growth forecast for next year Axsome Therapeutics
Fundamental company valuation:Axsome Therapeutics Inc, AXSM
Axsome Therapeutics (AXSM) is integrating ESG standards into neuropharmaceuticals, optimizing chemical technical processes and clinical trial ethics for sustainable development. The valuation of next year's EPS dynamics digitizes these efforts through aggregated analyst forecasts for net profit growth, allowing investors to weigh potential returns against liquidity risks and protect capital from volatility when exiting a position.
Main competitors
BIIB (Biogen Corp) - Earnings growth forecast for next year|Expected net earnings per share growth next year Neurocrine Corp NBIX|Expected earnings per share growth for next year RGC (Regencell Bioscience)|ACAD (acadia-pharm.com) - Expected earnings per share trend next year|Xenon - Expected earnings per share growth for next year|Projected earnings per share increase next year VKTX (Viking Therapeutics Inc)|Supernus Pharma - Earnings growth forecast for next year|Expected earnings per share trend next year CPRX (Catalyst Corp)|DNLI: Earnings growth forecast for next year|Expected net earnings per share growth next year harmonybiosciences.com (HRMY)|Net earnings per share growth forecast for next year Biohaven|AMLX: Expected earnings per share trend next year|Earnings growth forecast for next year TRVI|Earnings growth forecast for next year Praxis Corp (PRAX)|Net earnings per share growth forecast for next year Anavex Life Sciences AVXL|CBLL (ceribell.com) - Net earnings per share change forecast for next year|Prothena - Earnings growth forecast for next year|Expected net earnings per share growth next year Alector, Inc.|ANNX (Annexon Inc.) - Expected earnings per share growth for next year|Omeros (OMER) - Earnings growth forecast for next year|Expected earnings per share growth for next year NGNE|ACIU (acimmune.com) - Projected earnings per share increase next year|Earnings growth forecast for next year VYGR|Consensus forecast of earnings per share growth for next year Neumora|Earnings growth forecast for next year SCLX (Scilex Holding Co.)|TVGN - Expected earnings per share growth for next year|ACOG - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Cognition Therapeutics Inc. CGTX|IKT: Earnings growth forecast for next year|Cassava Sciences Inc (SAVA) - Earnings growth forecast for next year|Expected earnings per share growth for next year ASRT|Projected earnings per share growth rate for next year COYA (Coya)|Net earnings per share growth forecast for next year Vistagen Therapeutics (VTGN)|Consensus forecast of earnings per share growth for next year ovidrx.com|Net earnings per share growth forecast for next year Acumen Pharmaceuticals, Inc. ABOS|CRVO - Expected earnings per share growth for next year|ATHE - Net earnings per share growth forecast for next year|CLNN (Clene Inc.) - Projected earnings per share growth rate for next year|PEPG: Earnings growth forecast for next year|Expected net earnings per share growth next year Jupiter Neurosciences, Inc. (JUNS)|Expected earnings per share growth for next year RLMD|Earnings growth forecast for next year Annovis Bio Inc|Net earnings per share growth forecast for next year Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Klotho Neurosciences KLTO|NeuroSense Therapeutics Ltd (NRSN) - Expected net earnings per share growth next year|Reviva Pharmaceuticals Holdings, Inc. - Earnings growth forecast for next year|MTVA - Earnings growth forecast for next year|NRXS (NeurAxis, Inc) - Expected earnings per share growth for next year|Projected earnings per share growth rate for next year HSDT|Net earnings per share growth forecast for next year Passage Bio Inc.|Neuphoria (NEUP) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Minerva Neurosciences, Inc. (NERV)|ATHA - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Addex Therapeutics, Ltd. ADXN|ALZN - Expected earnings per share growth for next year|Cyclerion - Earnings growth forecast for next year|Expected net earnings per share growth next year Protagenic Therapeutics|KTTA (pasitheaclinics.com) - Expected earnings per share growth for next year|Cortigent - Expected earnings per share trend next year|Expected earnings per share growth for next year ATXI|BCLI (BrainStorm Cell Therapeutics Inc.) - Projected earnings per share increase next year|Earnings growth forecast for next year CARA|CHRO (chromocell.com) - Expected earnings per share trend next year|Earnings growth forecast for next year ELYM (Eliem Therapeutics Inc.)|Intra-Cellular Therapies Inc. (ITCI) - Expected net earnings per share growth next year|LBPH - Net earnings per share growth forecast for next year|Expected earnings per share trend next year MRNS (Marinus Pharma)|NKGN: Earnings growth forecast for next year|neurobopharma.com (NRBO) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Sage Therapeutics|Synaptogenix Inc. - Net earnings per share change forecast for next year|Earnings growth forecast for next year TRVN|VIGL - Expected net earnings per share growth next year|Anew Medical - Expected earnings per share growth for next year|Earnings growth forecast for next year cerevel.com CERE
